{"entities":{"Q100703":{"pageid":102022,"ns":120,"title":"Item:Q100703","lastrevid":84644981,"modified":"2026-05-28T08:22:43Z","type":"item","id":"Q100703","labels":{"en":{"language":"en","value":"Keyboard: A Novel Bayesian Toxicity Probability Interval Design for Phase I Clinical Trials"}},"descriptions":{"en":{"language":"en","value":"scientific article"}},"aliases":{},"claims":{"P31":[{"mainsnak":{"snaktype":"value","property":"P31","hash":"fd5912e4dab4b881a8eb0eb27e7893fef55176ad","datavalue":{"value":{"entity-type":"item","numeric-id":56887,"id":"Q56887"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q100703$16BEC9E2-6A80-493F-8F08-63871342F0B7","rank":"normal"}],"P200":[{"mainsnak":{"snaktype":"value","property":"P200","hash":"90d7cf0f01d87fadc1672c233a23b31df268de2e","datavalue":{"value":{"entity-type":"item","numeric-id":71902,"id":"Q71902"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q100703$1DE99C95-8517-4CCF-8707-05B8530CEDEA","rank":"normal"}],"P26":[{"mainsnak":{"snaktype":"value","property":"P26","hash":"44dc7c2dfe563f865c069079f99e746133e1f927","datavalue":{"value":"23","type":"string"},"datatype":"string"},"type":"statement","id":"Q100703$4487AE47-CF76-4828-A666-1AF87B90A39F","rank":"normal"}],"P25":[{"mainsnak":{"snaktype":"value","property":"P25","hash":"7f86145b9e6a5eca4e78101074ee730e5e5af5b5","datavalue":{"value":"15","type":"string"},"datatype":"string"},"type":"statement","id":"Q100703$AA6B9128-D546-4259-9ED5-762F7B9DC882","rank":"normal"}],"P128":[{"mainsnak":{"snaktype":"value","property":"P128","hash":"a13e5a135571e8053307734a2a1ccc592a126d20","datavalue":{"value":"3994-4003","type":"string"},"datatype":"string"},"type":"statement","id":"Q100703$F97E8277-A382-49CA-A063-D75FEF6F71E8","rank":"normal"}],"P28":[{"mainsnak":{"snaktype":"value","property":"P28","hash":"91fcf1a325353535172ee8049b2c7dae8fda1d1f","datavalue":{"value":{"time":"+2017-08-01T00:00:00Z","timezone":0,"before":0,"after":0,"precision":11,"calendarmodel":"http://www.wikidata.org/entity/Q1985727"},"type":"time"},"datatype":"time"},"type":"statement","id":"Q100703$452721EA-C326-4DE5-AFEA-76EE9F142BA2","rank":"normal"}],"P1460":[{"mainsnak":{"snaktype":"value","property":"P1460","hash":"57f7fea50d2ce1b39b695c4a1313582eed405e38","datavalue":{"value":{"entity-type":"item","numeric-id":5976449,"id":"Q5976449"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q100703$5861F47D-C1AD-4F6E-BF60-C0E42CFD4F76","rank":"normal"}],"P12":[{"mainsnak":{"snaktype":"value","property":"P12","hash":"70ff69e7ac05b685b930b1daef6a065b46a9d221","datavalue":{"value":"Q53265989","type":"string"},"datatype":"external-id"},"type":"statement","id":"Q100703$1DB4FEE5-891A-4602-B910-8D6319F35959","rank":"normal"}],"P27":[{"mainsnak":{"snaktype":"value","property":"P27","hash":"99d4cbd06ad2f1baf670abe3e8bbbc458c502bac","datavalue":{"value":"10.1158/1078-0432.CCR-17-0220","type":"string"},"datatype":"external-id"},"type":"statement","id":"Q100703$6CE7E391-F4C3-46E5-AD37-4DF255B6DF26","rank":"normal"}],"P43":[{"mainsnak":{"snaktype":"value","property":"P43","hash":"d9e901496472b2303ad9b856eeffae4ef83f61bc","datavalue":{"value":"Fangrong Yan","type":"string"},"datatype":"string"},"type":"statement","id":"Q100703$5FEFD585-D4E5-4DC1-99E9-A577A35170D1","rank":"normal"},{"mainsnak":{"snaktype":"value","property":"P43","hash":"be552a5b4530435bf0c89bf9b3a64497e7e2980d","datavalue":{"value":"Sumithra J. Mandrekar","type":"string"},"datatype":"string"},"type":"statement","id":"Q100703$B83EDD69-17BE-46D3-80FF-F64A65EBFD95","rank":"normal"},{"mainsnak":{"snaktype":"value","property":"P43","hash":"95a003d00fed838b40d0c75c818b493cd045a244","datavalue":{"value":"Ying Yuan","type":"string"},"datatype":"string"},"type":"statement","id":"Q100703$0EC9E601-EFE6-4D5C-9DAE-17D8FD8CAF70","rank":"normal"}]},"sitelinks":{"mardi":{"site":"mardi","title":"Keyboard: A Novel Bayesian Toxicity Probability Interval Design for Phase I Clinical Trials","badges":[]}}}}}